Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLESENCE, INC. Director's Dealing 2014

Aug 25, 2014

33563_dirs_2014-08-25_6123febb-dd93-40ef-96e7-fdfd0da3ea30.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2014-08-22

Reporting Person: WHITMORE R JANET (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-22 Common Stock P 3170 $0.43 Acquired 700480 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 32675 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $1.36 2021-01-31 Common Stock (10000) 10000 Direct
Deferred Common Stock $ Common Stock (2000) 20030 Direct
Stock Appreciation Right $0.99 Common Stock (2000) 14000 Direct
Stock Option (right to buy) $0.30 2022-08-07 Common Stock (10000) 10000 Direct
Stock Option (right to buy) $0.415 2023-02-14 Common Stock (10000) 10000 Direct
Stock Option (right to buy) $0.52 2024-02-13 Common Stock (10000) 10000 Direct

Footnotes

F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.

F2: Each share of deferred common stock represents a right to receive one share of common stock.

F3: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.

F4: Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.

F5: The stock appreciation right becomes payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99.

F6: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.